We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Scientists at NIH and Emory Achieve Sustained SIV Remission in Monkeys

The finding suggest that the immune systems of these animals are controlling SIV replication in the absence of antiretroviral therapy.
News

SeraCare Life Sciences, AAB Partner

Partnership aims to develop preimplantation genetic screening (PGS) reference materials for AAB proficiency testing service.
News

Teva, Celltrion Partner

Partnership aims to commercialize biosimilars to Rituxan, Herceptin.
News

Teligent Opens Product Development Lab in Estonia

The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company's North American markets.
News

Lonza, Forty Seven Manufacturing Agreement

Lonza and Forty Seven, Inc., announce strategic manufacturing agreement for immuno-oncology therapeutic antibody pipeline.
News

Nitto Denko Avecia Acquires Irvine & Avrio

Acquisition to expand Avecia's analytical capabilities.
News

Charles River, Genentech Extend Discovery Alliance

Alliance to provide a three-year continuation for early discovery services.
News

Twist Bioscience, Distributed Bio Partner

Partnership aims to offer therapeutic antibody design and optimization services, as well as an exclusive GPCR targeting library, for Twist Bioscience customers.
News

Untangling a Cause of Memory Loss in Neurodegenerative Diseases

The mouse study identifies a possible therapeutic target for a family of disorders.
News

PhoreMost, University of Cambridge Collaborate

Collaboration aims to identify innovative drug targets for neurodegenerative disease.
Advertisement